Histogen Granted European Patent Titled ‘EXTRACELLULAR MATRIX COMPOSITIONS’

https://register.epo.org/application?number=EP09706122

https://register.epo.org/application?number=EP09706122

Total
0
Shares
Related Posts
Read More

DZS Receives Favorable Nasdaq Listing Decision; Granted The Request Of DZS Inc. For Continued Listing On The Nasdaq Stock Market, Subject To The Co’s Compliance With Nasdaq’s Filing Requirement By August 5, 2024, Among Other Conditions

DZS (NASDAQ:DZSI), a global leader of broadband networking and AI-driven cloud software solutions, today announced that by decision dated April 23, 2024, the Nasdaq Hearings Panel (the "Panel") granted the request of DZS

DZSI